US 12310929
Use of rasagiline for the treatment of restless legs syndrome
granted A61KA61K2300/00A61K31/135
Quick answer
US patent 12310929 (Use of rasagiline for the treatment of restless legs syndrome) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue May 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K2300/00, A61K31/135, A61K31/16, A61K31/428